IP Library Granted Patent US 12,496,179
Granted Patent B2
US 12,496,179 · App. 18/529,947 · Granted Dec 16, 2025

Method and apparatus for creating a modified tissue graft

Inventor: Barry Markman (Frisco, TX)
Assignee: CellTherX Corp
A61F2/0077A61F2/0063A61L27/54A61F2002/0068A61F2002/0081A61F2240/002A61F2240/005A61F2250/0026A61F2250/0048A61F2250/0051A61F2250/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,496,179
App. No.
18/529,947
Granted
Dec 16, 2025
Kind
B2
Abstract

In a method of creating a modified tissue graft, at least one exterior surface of a graft is modified by compressing, cutting and/or removing one or more portions thereof to create designed surface features which cause the tissue graft to have characteristics for a specific anatomical area. Medicants are associated with the surface features of the tissue graft, or with a second graft or layer which is associated with a base tissue graft. The tissue graft may be modified by pressing a specially configured template or die having blades thereon into the tissue graft to create a pattern of partial depth cuts.

Claims (16)

1 . A multi-layer, medicated, reconstructive tissue graft comprising:

a base tissue graft having a top surface and a bottom surface, said base tissue graft modified by compressing, cutting and/or removing one or more portions of either or both said top surface and said bottom surface to create one or more designed surface features;

a second graft layer or sheet applied to either or both said top surface and said bottom surface of said base tissue graft; and

one or more medicants associated with said multi-layer reconstructive graft.

2 . The multi-layer graft in accordance with claim 1 , wherein said one or more medicants are associated with said designed surface features and said second graft layer is placed over said designed surface features.

3 . The multi-layer graft in accordance with claim 1 , wherein said medicants are associated with said second graft layer or sheet.

4 . The multi-layer graft in accordance with claim 3 , wherein said second graft layer or sheet comprises a amnion membrane allograft and said one or more medicants are associated with said allograft.

5 . The multi-layer graft in accordance with claim 3 , wherein said second graft layer or sheet comprises a sheet and said medicants are associated with said sheet.

6 . The multi-layer graft in accordance with claim 1 , wherein said one or more medicants are injected or inserted into said base tissue graft through said second graft layer or sheet.

7 . The multi-layer graft in accordance with claim 6 , wherein said one or more medicants are injected using a needle which is passed through said second graft layer or sheet.

8 . The multi-layer graft in accordance with claim 1 , wherein said base tissue graft is configured to comprise human tissue.

9 . The multi-layer graft in accordance with claim 8 , wherein said human tissue is configured to comprise soft, non-bone tissue.

10 . The multi-layer graft in accordance with claim 1 , wherein said one or more medicants comprise at least one of: an antibiotic, a hormone, a growth factor, and a chemo-therapeutic agent.

11 . The multi-layer graft in accordance with claim 1 , wherein said second graft layer or sheet comprises an amnion membrane allograft.

12 . The multi-layer graft in accordance with claim 1 , wherein a template or die having one or more blades is used to compress, cut and/or remove said one or more portions of either or both said top surface and said bottom surface.

13 . The multi-layer graft in accordance with claim 1 , wherein said designed surface features are designed to have characteristics which depend upon an anatomical site at which the graft is to be placed.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF APPLICANT PREVIOUSLY RECORDED ON REEL 67051 FRAME 308. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 16, 2025
From: MARKMAN BIOLOGICS CORPORATION
To: CELLTHERX CORP
Reel/Frame 072050/0092 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2024
From: MARKMAN BIOLOGICS CORPORATION
To: CELLTHERX
Reel/Frame 067051/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2024
From: MARKMAN, BARRY
To: MARKMAN BIOLOGICS CORPORATION
Reel/Frame 066719/0551 →
Continuity (10)
Division 16831169 · Mar 26, 2020
Continuation In Part 16657124 · Oct 18, 2019
Continuation In Part 16410167 · May 13, 2019
Continuation 15487585 · Apr 14, 2017
Continuation 14678188 · Apr 3, 2015
Continuation In Part 13687082 · Nov 28, 2012
Continuation 13101022 · May 4, 2011
Provisional Application 62805032 · Feb 13, 2019
Provisional Application 61331805 · May 5, 2010
Related Publication 20240122693A1 · Apr 18, 2024
References Cited (57)
US 4950296A · McIntyre · 1990 [cited by applicant]
US 5728159A · Stroever et al. · 1998 [cited by applicant]
US 5759205A · Valentini · 1998 [cited by applicant]
US 6190255B1 · Thomas et al. · 2001 [cited by applicant]
US 6280328B1 · Holch et al. · 2001 [cited by applicant]
US 6911220B1 · Sachs · 2005 [cited by applicant]
US 6949252B2 · Mizuno et al. · 2005 [cited by applicant]
US 7066962B2 · Swords · 2006 [cited by applicant]
US 7189259B2 · Simionescu et al. · 2007 [cited by applicant]
US 7282165B2 · Williams, III et al. · 2007 [cited by applicant]
US 7416546B2 · Pugsley et al. · 2008 [cited by applicant]
US 7427284B2 · Seedhom et al. · 2008 [cited by applicant]
US 7458975B2 · May et al. · 2008 [cited by applicant]
US 7520898B2 · Re et al. · 2009 [cited by applicant]
US 7572298B2 · Roller et al. · 2009 [cited by applicant]
US 7645568B2 · Stone · 2010 [cited by applicant]
US 7723108B2 · Truncale et al. · 2010 [cited by applicant]
US 7727278B2 · Olsen et al. · 2010 [cited by applicant]
US 7776089B2 · Bianchi et al. · 2010 [cited by applicant]
US 7815923B2 · Johnson et al. · 2010 [cited by applicant]
US 8372437B2 · Daniel · 2013 [cited by applicant]
US 8460715B2 · Daniel · 2013 [cited by applicant]
US 8500740B2 · Bojarski et al. · 2013 [cited by applicant]
US 8597687B2 · Daniel · 2013 [cited by applicant]
US 8741646B2 · Emig et al. · 2014 [cited by applicant]
US 8858647B2 · Markman · 2014 [cited by applicant]
US 9050177B2 · Markman · 2015 [cited by applicant]
US 9622845B2 · Markman · 2017 [cited by applicant]
US 10105862B1 · Koch et al. · 2018 [cited by applicant]
US 11246697B2 · Markman · 2022 [cited by examiner]
US 11701213B2 · Markman · 2023 [cited by applicant]
US 12048617B2 · Markman · 2024 [cited by examiner]
US 20030036770A1 · Markman · 2003 [cited by examiner]
US 20040049270A1 · Gewirtz · 2004 [cited by applicant]
US 20040057938A1 · Ghinelli · 2004 [cited by applicant]
US 20040082063A1 · Deshpande et al. · 2004 [cited by applicant]
US 20060018838A1 · George et al. · 2006 [cited by applicant]
US 20060219143A1 · Brennan et al. · 2006 [cited by applicant]
US 20070061015A1 · Jensen et al. · 2007 [cited by applicant]
US 20090291116A1 · Casellas et al. · 2009 [cited by applicant]
US 20100119755A1 · Chung et al. · 2010 [cited by applicant]
US 20100137903A1 · Lee et al. · 2010 [cited by applicant]
US 20100161032A1 · Avellanet · 2010 [cited by applicant]
US 20100228335A1 · Schorgl et al. · 2010 [cited by applicant]
US 20110022171A1 · Richter et al. · 2011 [cited by applicant]
US 20140348940A1 · Murphy et al. · 2014 [cited by applicant]
US 20150139960A1 · Tumey et al. · 2015 [cited by applicant]
US 20150209128A1 · Markman · 2015 [cited by applicant]
US 20150342725A1 · Cuevas et al. · 2015 [cited by applicant]
US 20160256259A1 · Wirth et al. · 2016 [cited by applicant]
US 20170367807A1 · Chen et al. · 2017 [cited by applicant]
US 20180228938A1 · McGuire et al. · 2018 [cited by applicant]
US 20250032239A1 · Markman · 2025 [cited by examiner]
CN 105165803 · 2015 [cited by applicant]
WO 2001045566 · 2001 [cited by applicant]
PCT Search Report and Written Opinion for International Application No. PCT/US2021/022691, mailed Aug. 31, 2021, 15 pages. [cited by applicant]
PCT Search Report and Written Opinion for International Application No. PCT/US2019/057005, dated Jan. 6, 2020, 12 pages. [cited by applicant]